FindTrial
Sign In

A clinical study on Vadavanala Ras in the management of Cholesterol.

Pharmaceutico - Analytical study of Vadavanala Ras and it s clinical evaluation in the management of Medo roga w.s.r to Dyslipidemia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083980
Enrollment
30
Registered
2025-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Sponsors

Dr SRIKANTH VUYYURU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients within the age group of 18-60 years of either gender. 2.Diagnosed cases of Dyslipidemia. 3.Patients with borderline high to very high lipid level in blood serum as per the ATP-3 Classification. 4.Having not taken any LLDs within the past 1 month. 5.Having voluntarily given their informed consent.

Exclusion criteria

Exclusion criteria: 1. Age below 18 years and above 60 years. 2. Known / diagnosed cases of severe renal disease, hepatic disease, coronary heart disease or myocardia infraction and other systemic diseases. 3.Uncontrolled hypertension, diabetes mellitus and malignancy patients. 4.Undergoing treatment for any other serious illness. 5.Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Relief in signs and symptoms, Significant improvement in Objective ParametersTimepoint: 15 days—

Secondary

MeasureTime frame
Relief in body stiffness, Pains (Myalgia), reduction in body weight.Timepoint: Treatment period of 60 days, Assessment for every 15 days with active follow up of 3 months—

Countries

India

Contacts

Public ContactDr SRIKANTH VUYYURU

Dr. N R S Govt Ayurvedic College, Vijayawada

dr.skovi@gmail.com7989325008

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026